Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for heart rate reduction in patients with multiple organ dysfunction syndrome
2009-015499-88Phase 2Completed
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ivabradine in multiple organ dysfunction syndrome (MODS), sponsored by Martin Luther University Halle-Wittenberg. Primary endpoint: Mean heart rate reduction at 96 hours. Started Dec 2009; status: completed.
02
Drugs
ivabradine
03
Conditions
multiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on 2009-015499-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015499-88.